Register information Patent

DE file number : 60 2015 048 668.4 (Status: pending/in force, Query started: April 24, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2015 048 668.4
96EP file numberEAKZ15 79 0325.3
86WO file numberWAKZPCT/US2015/054959
97EP publication numberEPN3204497
87WO publication numberWPN2016057932
54Designation/titleTITHERAPEUTISCHE HEMMUNG DER LAKTATDEHYDROGENASE UND MITTEL DAFÜR
51IPC main classICM
(ICMV)
C12N 15/113 (2010.01)
51IPC secondary class(es)ICS
(ICSV)
A61K 31/7088 (2006.01), A61P 7/00 (2006.01), A61P 13/12 (2006.01), A61P 35/00 (2006.01)
22DE application dateDATOct 9, 2015
96EP application dateEATOct 9, 2015
86WO application dateWATOct 9, 2015
43Date of first publicationOTApr 14, 2016
Date of publication of grantPETMar 11, 2020
71/73Applicant/ownerINHNovo Nordisk Health Care AG, Zürich, CH
72InventorINBROWN, Bob D., Littleton, MA 01460, US; DUDEK, Henryk T., Wellesley, MA 02482, US; LAI, Cheng, Belmont, MA 02478, US
74RepresentativeVTRHernandez, Yorck, Dipl.-Ing., 82031 Grünwald, DE
Address for service HERNANDEZ IP, 82031 Grünwald, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201462062424 P
Oct 10, 2014
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201562199056 P
Jul 30, 2015
Due dateFT
FG
Oct 31, 2025
Annual fee for the 11th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003204497A1
Searchable text: EP000003204497A1
Original document: EP000003204497B1
Searchable text: EP000003204497B1
Original document: WO002016057932
Searchable text: WO002016057932
43Date of first publicationEVTApr 14, 2016
Date of the first transfer into DPMAregisterEREGTAug 17, 2017
Date of the (most recent) update in DPMAregisterREGTSep 27, 2024
(Show all update days)(Hide all update days)
  • Sep 27, 2024
    • Due date: changed
    • Procedures: Procedure relating to PCT application, Publication of PCT application, 14.04.2016: deleted
  • Sep 29, 2023; Mar 23, 2023; Feb 10, 2023; Nov 4, 2022; Oct 30, 2021; Jul 8, 2021; Feb 25, 2021; Jan 28, 2021; Jan 22, 2021; Dec 5, 2020; Dec 4, 2020; May 12, 2020; Apr 2, 2020; Feb 25, 2020; Feb 20, 2020; Aug 22, 2019; Mar 14, 2019
    • Historical data not available for this/these date(s)
  • Aug 17, 2017
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Apr 14, 2016  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Aug 16, 2017  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Sep 28, 2017 Sep 28, 2017 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Mar 11, 2020  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Apr 2, 2020 Apr 2, 2020 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Dec 14, 2020 Mar 4, 2021 Details anzeigen
7 New applicant/owner details New applicant/owner details Feb 9, 2023 Mar 23, 2023 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTApr 14, 2016
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTAug 16, 2017
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTSep 28, 2017
Issue numberHN39
YearPJ2017
Publication dateVTSep 28, 2017
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTMar 11, 2020
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTApr 2, 2020
Issue numberHN14
YearPJ2020
Publication dateVTApr 2, 2020
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTDec 14, 2020
Issue numberHN9
YearPJ2021
Publication dateVTMar 4, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTFeb 25, 2021
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTFeb 9, 2023
Issue numberHN12
YearPJ2023
Publication dateVTMar 23, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHNovo Nordisk Health Care AG, Zürich, CH
71/73Previous applicant/ownerINHFDicerna Pharmaceuticals, Inc., Lexington, MA, US
Date of update of the procedureREGTMar 23, 2023